FDA hits pause on one of the first US human clinical trials to use CRISPR

The CRISPR-Cas9 gene editing system has revolutionized medical research, but since its discovery in 2012 progress towards human trials has been slow. Now another setback has appeared with the FDA pausing one of the first human trials using the technique in the United States before it even begins.

Source: FDA hits pause on one of the first US human clinical trials to use CRISPR